Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Stock Information for Protara Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.